Treatment of myelodysplastic syndromes with 5q deletion before the lenalidomide era; the GFM experience with EPO and thalidomideCharikleia Kelaïdi, Pierre Fenaux, Lionel Adès et al.|Leukemia Research|2008Cited by 78